Literature DB >> 24881077

Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey.

Vincent Cottin1.   

Abstract

This review presents the results of the 2013 Advancing IPF Research (AIR) survey, which assessed current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) by experienced physicians. A total of 149 physicians, predominantly from European countries, replied to the 28-question survey. The results of the AIR survey were compared with a similar survey of 509 French pulmonologists conducted by the French National Reference Centre and the Network of Regional Competence Centres for Rare Lung Diseases. A number of positive findings emerged from the AIR survey, including the high level of multidisciplinary team involvement in both diagnosis and management. This survey, when taken together with the French survey, suggests that there is still a need to improve earlier diagnosis of IPF. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24881077     DOI: 10.1183/09059180.00001914

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  8 in total

1.  Survey of Physician's Knowledge, Attitudes, and Practices Regarding Idiopathic Pulmonary Fibrosis in Turkey.

Authors:  Haluk Türktaş; Gülfer Okumuş; Oğuz Uzun; Özlem Özdemir Kumbasar; Göksel Altınışık; Züleyha Bingöl; Şermin Börekçi; Vincent Cottin; Benan Müsellim
Journal:  Turk Thorac J       Date:  2020-01-01

2.  Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey.

Authors:  Vincent Cottin; Emmanuel Bergot; Arnaud Bourdin; Jacques Cadranel; Philippe Camus; Bruno Crestani; Jean-Charles Dalphin; Philippe Delaval; Claire Dromer; Dominique Israel-Biet; Romain Kessler; Sylvain Marchand-Adam; Charles Hugo Marquette; Grégoire Prévot; Martine Reynaud-Gaubert; Dominique Valeyre; Benoit Wallaert; Benoit Bouquillon; Jean-François Cordier
Journal:  ERJ Open Res       Date:  2015-11-16

3.  Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America.

Authors:  Iván Cherrez-Ojeda; Vincent Cottin; Juan Carlos Calderón; César Delgado; Erick Calero; Daniel Simanca-Racines; Silvia Quadrelli; Annia Cherrez
Journal:  BMC Pulm Med       Date:  2018-01-10       Impact factor: 3.317

4.  Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry.

Authors:  Laurie D Snyder; Christopher Mosher; Colin H Holtze; Lisa H Lancaster; Kevin R Flaherty; Imre Noth; Megan L Neely; Anne S Hellkamp; Shaun Bender; Craig S Conoscenti; Joao A de Andrade; Timothy Pm Whelan
Journal:  BMJ Open Respir Res       Date:  2020-07

Review 5.  Patient Registries in Idiopathic Pulmonary Fibrosis.

Authors:  Daniel A Culver; Jürgen Behr; John A Belperio; Tamera J Corte; Joao A de Andrade; Kevin R Flaherty; Mridu Gulati; Tristan J Huie; Lisa H Lancaster; Jesse Roman; Christopher J Ryerson; Hyun J Kim
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

Review 6.  Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.

Authors:  Fabrizio Luppi; Stefania Cerri; Sofia Taddei; Giovanni Ferrara; Vincent Cottin
Journal:  Intern Emerg Med       Date:  2015-02-12       Impact factor: 3.397

7.  Effects of oral anticoagulant therapy in patients with pulmonary diseases.

Authors:  Jiying Lai; Shenghui Feng; Shuo Xu; Xin Liu
Journal:  Front Cardiovasc Med       Date:  2022-08-10

8.  Inhibitory effects of amines from Citrus reticulata on bleomycin-induced pulmonary fibrosis in rats.

Authors:  Xian-Mei Zhou; Zhen-Dong Cao; Na Xiao; Qi Shen; Jian-Xin Li
Journal:  Int J Mol Med       Date:  2015-12-15       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.